Delphinus Medical Technologies Inc
✓ Verified ManufacturerAbout
Delphinus Medical Technologies Inc, headquartered in Novi, Michigan, is a pioneering healthcare company revolutionizing breast cancer detection through innovative medical imaging technology. Founded in 2010, Delphinus specializes in advanced ultrasound systems designed to address the critical limitations of traditional mammography, particularly for women with dense breast tissue. The company's flagship product, SoftVue, represents a breakthrough in whole breast ultrasound tomography, featuring proprietary TriAD technology that incorporates over 2,000 transducer elements within a uniform ring configuration. This FDA-approved system delivers radiation-free, compression-free imaging that captures the entire breast in a single scan. SoftVue has received both 510(k) clearance for diagnostic imaging and PMA approval specifically for dense breast screening, demonstrating a 25% increase in cancer detection when combined with mammography. Delphinus Medical Technologies addresses a significant healthcare challenge, as mammography misses more than 50% of cancers in dense breasts, affecting 40% of women in the United States. The company's innovative approach utilizes reflected echoes while quantifying sound speed and attenuation signals transmitted through breast tissue. In 2024, Delphinus received prestigious recognition from Premier Inc with a Technology Breakthrough designation and national group purchasing agreement, validating their commitment to improving patient safety and clinical outcomes in women's healthcare.